CN102552248A
|
|
Application of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma
|
CN102531989A
|
|
Purification method for (S)-oxiracetam
|
CN102531988A
|
|
Purification method for sinistrogyration oxiracetam
|
CN102249977A
|
|
4-hydroxy-2-oxo-1-pyrrolidine acetamide racemate crystal I and preparation method thereof
|
CN102743218A
|
|
Porous tantalum rod
|
CN102603600A
|
|
Method for preparing (S)-oxiracetam
|
CN102603596A
|
|
Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide
|
CN102603607A
|
|
Preparation method of (R)-oxiracetam
|
CN102603602A
|
|
Preparation method of oxiracetam
|
CN102603595A
|
|
Preparation method of (S)-oxiracetam
|
CN102603606A
|
|
Preparation method of (S)-oxiracetam
|
CN102603599A
|
|
Method for preparing (S)-oxiracetam
|
CN102603598A
|
|
Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide
|
CN102603603A
|
|
Method for preparing (S)-oxiracetam
|
CN102475904A
|
|
Preparation method of medical porous metal implant material
|
CN102475903A
|
|
Preparation method for medical metal implant material porous niobium
|
CN102451911A
|
|
Method for preparing medical metal implantation material porous tantalum
|
CN102442936A
|
|
Purifying method of (S)-4-hydroxyl-2oxo-1-pyrrolidine acetamide
|
WO2011147139A1
|
|
Porous niobium used as metal medical implant material and preparation method thereof
|
CN102249974A
|
|
Preparation method of (s)-4-hydroxy-2-oxo-1-pyrrolidineacetamide
|